FindTrial
Sign In

Study on the effect and mechanism of Erzhitiangui granule in improving the pregnancy outcome of advanced age patients with IVF infertility

Study on the effect and mechanism of Erzhitiangui granule in improving the pregnancy outcome of advanced age patients with IVF infertility

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2200006728
Enrollment
Unknown
Registered
2022-10-31
Start date
2022-11-01
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

infertile women of advanced reproductive age

Interventions

Treatment group:Erzhi Tiangui Granules
Control group:Conventional therapy

Sponsors

Reproductive Hospital Affiliated to Shandong University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
35 Years to 42 Years

Inclusion criteria

Inclusion criteria: ? Age 35-42 years old; FSH 5; ? Patients with tubal factors to undergo IVF; ? Normal liver and kidney function, no gynecological and other systemic diseases.

Exclusion criteria

Exclusion criteria: ?Uterine malformation,including single horn uterus, uterine cavity adhesion;?Severe diseases, including diseases of cardiovascular, cerebrovascular, liver, kidney and hematopoietic systems, and mental illness; ?Received hormone drug therapy within last six month; ? Allergic to the drug used in this study; ?Taken other traditional Chinese medicine treating infertility in the past three month.

Design outcomes

Primary

MeasureTime frame
pregnancy outcome;—

Countries

China

Contacts

Public ContactXiufang Li
xiufang-82@163.com18668952218

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026